Brought to you by 
Camitro Corp. raises $8.6mm in Series B financing
26 Jul 2000
Executive Summary
Camitro Corp. (computational models for ADME prediction of drug candidates) raised $8.6 million in its Series B financing round, in which seed investor Alloy Management participated, as well as new investors CHL Investments, GIMV, Forward Ventures, and BayStar Capital.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Camitro Corp. raises $8.6mm in Series B financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice